Sensei Biotherapeutics, Inc.
SNSE
$8.05
-$0.15-1.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.51% | -21.40% | -28.46% | -34.61% | -32.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.71% | -17.39% | -15.66% | -16.91% | -22.13% |
| Operating Income | 26.71% | 17.39% | 15.66% | 16.91% | 22.13% |
| Income Before Tax | 19.00% | 9.60% | 9.05% | 11.57% | 23.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.00% | 9.60% | 9.05% | 11.57% | 23.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.00% | 9.60% | 9.05% | 11.57% | 23.43% |
| EBIT | 26.71% | 17.39% | 15.66% | 16.91% | 22.13% |
| EBITDA | 25.01% | 16.26% | 15.39% | 17.46% | 22.75% |
| EPS Basic | 19.41% | 9.68% | 4.04% | 1.04% | 9.56% |
| Normalized Basic EPS | 24.15% | 14.59% | 8.34% | 6.13% | 7.79% |
| EPS Diluted | 19.41% | 9.68% | 4.04% | 1.04% | 9.56% |
| Normalized Diluted EPS | 24.15% | 14.59% | 8.34% | 6.13% | 7.79% |
| Average Basic Shares Outstanding | 0.52% | 0.07% | -5.14% | -10.20% | -14.75% |
| Average Diluted Shares Outstanding | 0.52% | 0.07% | -5.14% | -10.20% | -14.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |